📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. (2022)

First Author: Nutalai R

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2022.05.014

PubMed Identifier: 35662412

Publication URI: http://europepmc.org/abstract/MED/35662412

Type: Journal Article/Review

Volume: 185

Parent Publication: Cell

Issue: 12

ISSN: 0092-8674